Atlas Trials

Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB

Clinical trial NCT04187469 · UNKNOWN

Trial details

NCT number
NCT04187469
Sponsor
Fifth Affiliated Hospital, Sun Yat-Sen University
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Pulmonary Tuberculosis
Start date
2020-03-01
Primary completion
2023-02-01
Enrollment
286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.